| Literature DB >> 29800681 |
Marie-Sarah Fangous1, Ismaïl Lazzouni2, Youenn Alexandre3, Stéphanie Gouriou4, Sylvie Boisramé5, Sophie Vallet6, Jean Le Bihan7, Sophie Ramel8, Geneviève Héry-Arnaud9, Rozenn Le Berre10.
Abstract
No prevalence or dynamics analysis of Lactobacilli in the lung of cystic fibrosis (CF) patients has yet been conducted. In order to use them as probiotics in the treatment of Pseudomonas aeruginosa infection, we describe their lung epidemiology. Over a period of 8 months, we analyzed 279 sputum samples from 124 CF patients classified according to their P. aeruginosa Leeds status of colonization. A total of 137 strains belonging to 11 species were isolated. The prevalence of carriage was 61%. No difference in species diversity or frequency was observed according to Leeds criteria. The next step will be to focus on the strain level.Entities:
Keywords: Cystic fibrosis; Lactobacillus; Probiotics; Pseudomonas aeruginosa; Respiratory tract
Mesh:
Year: 2018 PMID: 29800681 DOI: 10.1016/j.resmic.2018.03.005
Source DB: PubMed Journal: Res Microbiol ISSN: 0923-2508 Impact factor: 3.992